NAFLD fibrosis score può essere usato nei servizi ambulatoriali per identificare complicanze vascolari croniche oltre alla fibrosi epatica avanzata nel diabete tipo 2
Crossref DOI link: https://doi.org/10.1007/s40619-021-00947-9
Published Online: 2021-08-12
Published Print: 2021-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sterpetti, Sara
Buzzetti, Raffaella
Funding for this research was provided by:
UniversitĂ degli Studi di Roma La Sapienza
Text and Data Mining valid from 2021-08-01
Version of Record valid from 2021-08-12
Article History
Accepted: 21 December 2020
First Online: 12 August 2021